Protection against group B Neisseria meningitidis disease: preparation of soluble protein and protein-polysaccharide immunogens.
Although effective polysaccharide vaccines have been developed for meningococcal groups A, C, Y, and W135, the purified group B polysaccharide has proven to be nonimmunogenic. Earlier studies indicated that serotype 2 outer membrane protein vaccines induced bactericidal antibodies in animals and pro...
Tallennettuna:
| Julkaisussa: | Infect Immun |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Microbiology (ASM)
1982
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC347523/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6809629/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.37.1.271-280.1982 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|